EPISODE · Aug 29, 2023 · 57 MIN
Market access in the German speaking markets
from Pharma Market Access Insights - from Petauri Evidence · host Mtech Access
Send us Fan MailHere we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.Clare and Stefan discuss: - Preparing for access to Switzerland – a European market outside the EU - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) - Launching in Germany – is this still one of the most attractive European markets? - The Financial Stabilisation Act in Germany – what this means for drug pricingLearn more at: https://mtechaccess.co.uk/market-acce...This episode was first broadcast as a live webinar in July 2023. Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence
Embed this episode
What this episode covers
Send us Fan Mail Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets. Clare and Stefan discuss: - Preparing for access to Switzerland – a European market outside the EU - Pricing strategy and HTA decision-...
NOW PLAYING
Market access in the German speaking markets
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.